Mer­ck KGaA hands off its CAR-T R&D op­er­a­tions to In­trex­on in $175M deal

Mer­ck KGaA is bow­ing out of the CAR-T de­vel­op­ment busi­ness, hand­ing over its rights to In­trex­on $XON in ex­change for $150 mil­lion batch of stock.

The Ger­man Mer­ck is char­ac­ter­iz­ing the move as an R&D sim­pli­fi­ca­tion process, stay­ing fo­cused where they be­lieve they can make the most progress. And the deal comes three years af­ter the two com­pa­nies al­lied on CAR-T, with In­trex­on con­tribut­ing its tech — in­clud­ing Sleep­ing Beau­ty — for the pre­clin­i­cal work un­der­way.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER